|  | RA Control | MTX group | ABT/MTX group |
---|---|---|---|---|
n = 35 | n = 55 | n = 15 | ||
IgG GMCs (μg/ml) | ||||
6B | Before | 0.84(0.58 to 1.11) | 1.42(0.86 to 1.97) | 1.19(0.73 to 1.65) |
 | After | 4.05(2.13 to 5.97)* | 4.36(2.17 to 6.55)* | 2.49(0.29 to 4.70) |
 | Fold increase | 2.38(1.41 to 5.62) | 1.75(1.15 to 3.11) | 1.19(0.77 to 2.44) |
23F | Before | 1.17(0.85 to 1.48) | 1.79(1.33 to 2.25) | 1.17(0.63 to 1.71) |
 | After | 11.61(4.16 to 19.07)* | 7.41(4.48 to 10.33)* | 3.78(1.87 to 5.70)* |
 | Fold increase | 3.36(1.85 to 9.42) | 2.00(1.27 to 5.48) | 1.96(1.15 to 5.99) |
GM-OIs | ||||
6B | Before | 17.24(10.96 to 23.53) | 150.79(14.85 to 286.74) | 43.33(0.15 to 86.51) |
 | After | 981.15(407.24 to 1555.05)* | 584.29(270.29 to 898.28)* | 1454.80(109.29 to 2800.31)* |
 | Fold increase | 10.22(1.92 to 79.48) | 2.57(1.22 to 22.40) | 14.65(2.96 to 193.79) |
23F | Before | 63.21(−6.79 to 133.20) | 52.11(14.04 to 90.18) | 178.13(−130.27 to 486.54) |
 | After | 713.49(307.97 to 1119.01)* | 724.56(336.93 to 1112.19)* | 880.73(−81.54 to 1843.01)* |
 | Fold increase | 6.86(2.50 to 27.14) | 3.75(1.47 to 38.32) | 2.50(1.33 to 35.74) |